Zobair M. Younossi

Research interests

Publications

• A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

  New England Journal of Medicine · 2024 · 10.1056/nejmoa2309000

• A multisociety Delphi consensus statement on new fatty liver disease nomenclature

  Journal of Hepatology · 2023 · https://doi.org/10.1016/j.jhep.2023.06.003

• The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

  Hepatology · 2023 · 10.1097/hep.0000000000000004

• Advancing the global public health agenda for NAFLD: a consensus statement

  Nature Reviews Gastroenterology & Hepatology · 2021 · https://doi.org/10.1038/s41575-021-00523-4

• Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

  Gastroenterology · 2020 · https://doi.org/10.1053/j.gastro.2020.01.043

• MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

  Gastroenterology · 2020 · https://doi.org/10.1053/j.gastro.2019.11.312

• The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

  Journal of Hepatology · 2019 · 10.1016/j.jhep.2019.06.021

• Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)33041-7

• Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

  Clinical Gastroenterology and Hepatology · 2018 · 10.1016/j.cgh.2018.05.057

• Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

  Hepatology · 2018 · 10.1002/hep.30251

• Non-alcoholic fatty liver disease – A global public health perspective

  Journal of Hepatology · 2018 · 10.1016/j.jhep.2018.10.033

• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

  Hepatology · 2017 · 10.1002/hep.29367

• Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

  Hepatology · 2017 · 10.1002/hep.29466

• Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

  Nature Reviews Gastroenterology & Hepatology · 2017 · 10.1038/nrgastro.2017.109

• Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis

  Hepatology · 2017 · 10.1002/hep.29085

• The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

  Hepatology · 2016 · 10.1002/hep.28785

• Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes

  Hepatology · 2015 · 10.1002/hep.28431

• Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

  Gastroenterology · 2014 · 10.1053/j.gastro.2014.11.039

• Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

  New England Journal of Medicine · 2013 · 10.1056/nejmoa1214853

• The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

  Hepatology · 2012 · 10.1002/hep.25762

• The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

  Gastroenterology · 2012 · 10.1053/j.gastro.2012.04.001

• Telaprevir for Retreatment of HCV Infection

  New England Journal of Medicine · 2011 · 10.1056/nejmoa1013086

• Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

  Alimentary Pharmacology & Therapeutics · 2011 · 10.1111/j.1365-2036.2011.04724.x

• Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008

  Clinical Gastroenterology and Hepatology · 2011 · 10.1016/j.cgh.2011.03.020

• The utility of radiological imaging in nonalcoholic fatty liver disease

  Gastroenterology · 2002 · 10.1053/gast.2002.35354

• Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆

  Gastroenterology · 1999 · 10.1016/s0016-5085(99)70506-8

Current projects

No projects listed.